Approach to chemotherapy-associated thrombosis

Peter Oppelt, Anthony Betbadal, Lalitha Nayak

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


Treatment of cancer patients with antineoplastic agents is associated with a heightened risk of thrombotic events, both arterial and venous. In this article, we review the specific agents that are implicated and the pathophysiological processes that are known to be associated with this prothrombotic state. We conclude with current recommendations for prophylactic antithrombotic therapy in these clinical situations.

Original languageEnglish
Pages (from-to)153-161
Number of pages9
JournalVascular Medicine (United Kingdom)
Issue number2
StatePublished - Apr 4 2015


  • angiogenesis inhibitors
  • anticoagulants
  • endothelial cells
  • pulmonary embolism
  • review
  • thromboembolism
  • thrombosis
  • venous thrombosis


Dive into the research topics of 'Approach to chemotherapy-associated thrombosis'. Together they form a unique fingerprint.

Cite this